David N Liebowitz

age ~62

from Del Mar, CA

Get Report

Also known as:

David Neal Liebowitz
David M Liebowitz
David Liebowitz Neal
David Lievowitz
David Liebitz
David Z

Phone and address:: 13093 Caminito Pointe Del Mar, Del Mar, CA 92014
5757763909

Connected to:

David Liebowitz Phones & Addresses

13093 Caminito Pointe Del Mar, Del Mar, CA 92014 • 5757763909
El Prado, NM
Arroyo Hondo, NM
1790 Marina Way, San Jose, CA 95125
5406 Diamond Pl NE, Bainbridge Island, WA 98110
Redmond, WA
Santa Clara, CA

License Records

David Oren Liebowitz

License #:

5230 - Active

Category:

Nursing Home Administrator

Issued Date:

Dec 20, 2006

David I Liebowitz

License #:

038836-21 - Active

Category:

Nursing

Type:

Registered Nurse

David I Liebowitz

License #:

038836-21 - Active

Category:

Nursing

Type:

Registered Nurse

David Neal Liebowitz

Address:

Bainbridge Island, WA 98110

License #:

MD067547L - Expired

Category:

Medicine

Type:

Medical Physician and Surgeon

Us Patents

Methods For Treating Diabetes
view source
US Patent:

20060106014, May 18, 2006
Filed:

Oct 13, 2005
Appl. No.:

11/251423
Inventors:

Sekhar Boddupalli - San Jose CA, US
David Liebowitz - San Jose CA, US
Guy Miller - San Jose CA, US
International Classification:

A61K 31/5377
A61K 31/52
A61K 31/506
A61K 31/497
A61K 31/501
A61K 31/452
A61K 31/473
A61K 31/407
A61K 31/404
A61K 31/4015
A61K 31/353
US Classification:

514232500, 514252010, 514254110, 514255050, 514314000, 514263240, 514305000, 514320000, 514337000, 514248000, 514297000, 514414000, 514365000, 514372000, 514374000, 514411000, 514256000, 514422000, 514456000, 514406000, 514397000
Abstract:

Disclosed are methods for the treatment of diabetes by administering a composition comprising a pharmaceutically acceptable amount of a dual inhibitor of both 5-lipoxygenase (5-LO) and 12/15-lipoxygenase (12/15-LO) enzymes or of both 5-lipoxygenase (5-LO) and 15-lipoxygenase (15-LO) enzymes. The invention is also directed to methods of controlling blood glucose level in diabetic patients with a dual inhibitor of both 5-lipoxygenase (5-LO) and 12/15-lipoxygenase (12/15-LO) enzymes or of both 5-lipoxygenase (5-LO) and 15-lipoxygenase (15-LO) enzymes.

Methods Of Using Flt3-Ligand In Immunization Protocols
view source
US Patent:

20040022760, Feb 5, 2004
Filed:

Mar 26, 2003
Appl. No.:

10/401364
Inventors:

Hilary McKenna - Seattle WA, US
David Liebowitz - Seattle WA, US
Charles Maliszewski - Seattle WA, US
International Classification:

A61K039/00
A61K038/21
A61K038/19
A61K038/20
US Classification:

424/085100, 424/085700, 424/185100, 424/085200
Abstract:

The present invention relates to methods of using Flt3-ligand (Flt3-L) in immunization protocols to enhance immune responses against vaccine antigens. Embodiments include administering Flt3-ligand prior to immunizing a subject with a vaccine, wherein the vaccine comprises at least one antigen formulated in one or more adjuvants. Methods of treating and preventing disease and infection using Flt3-ligand immunization protocols are also provided. Methods of using Flt3-ligand immunization protocols for in vivo evaluation of antigens and adjuvants are also provided.

Dosing Of A Bispecific Antibody That Binds Cd20 And Cd3
view source
US Patent:

20230048390, Feb 16, 2023
Filed:

Jun 3, 2022
Appl. No.:

17/832093
Inventors:

- Monrovia CA, US
David LIEBOWITZ - San Diego CA, US
Assignee:

XENCOR, INC. - Monrovia CA
International Classification:

C07K 16/28
A61P 35/00
Abstract:

Provided herein, in certain aspects, are methods for the treatment of a CD20-expressing cancer in a human subject, comprising administration of a bispecific anti-CD20×anti-CD3 antibody.

Name / Title

Company / Classification

Phones & Addresses

David Liebowitz
Organizer

HIGH ALTITUDE CYCLING LLC

41 Sangre De Cristo Mtn Dr , Arroyo Hondo, NM 87513

David Liebowitz
Organizer, Principal

LIEBOWITZ CONSULTING LLC
Business Consulting Services

41 Sangre De Cristo Mtn Dr , Arroyo Hondo, NM 87513
PO Box 308, Arroyo Hondo, NM 87513

David Liebowitz

Liebowitz Consulting LLC
Pharmaceutical Research and Development

1790 Marina Way, San Jose, CA 95125

Resumes

Vice President, Clinical Oncology

view source

Location:

13093 Caminito Pointe Del Mar, Del Mar, CA 92014

Industry:

Biotechnology

Work:

Vivaldi Biosciences Inc - Fort Collins, Colorado Area since May 2007
Chief Scientific and Medical Officer
Vaxart Inc. - San Francisco Bay Area since 2012
Chief Medical Officer
Liebowitz Consulting LLC since Mar 2006
Owner / Principal
Galileo Pharmaceuticals Apr 2004 - Mar 2006
Executive Vice President of R&D, Chief Scientific Officer
Amgen Jun 2002 - Apr 2004
Director, Research

Education:

University of Chicago
University of Chicago - The Pritzker School of Medicine 1989 - 1992
MD University of Chicago - The Pritzker School of Medicine 1984 - 1989
PhD, Molecular Genetics and Cell Biology Emory University 1980 - 1984
MS, Biology Emory University 1980 - 1984
BS, Biology

Skills:

Drug Development
Lifesciences
Cancer
Biotechnology
Drug Discovery
Cancer Research
Oncology
Immunology
Clinical Development
Medicine
R&D
Translational Medicine
Infectious Diseases
Hematology
Virology
Cell
Biopharmaceuticals
Vaccines
Assay Development

David Liebowitz

view source

David Liebowitz

view source

David Liebowitz

view source

Location:

United States

Flickr

News

Blue KC sues COVID-19 testing company over test prices

view source

surgeon who pays $1 for a scalpel should be, you know, is entitled to $1 for surgery. At the beginning of the pandemic, when no tests were available anywhere, GS Labs got into and expanded its testing business. It was a $37 million upfront investment," said David Liebowitz, a spokesman for GS Labs.
Date: Nov 04, 2021
Category: More news
Source: Google